Metronidazole and Levofloxacin Combination Therapy

Guideline-Supported Indications

The Infectious Diseases Society of America and the Surgical Infection Society recommend the combination of levofloxacin plus metronidazole for adults and children with complicated intra-abdominal infections 1, 3
The combination is appropriate for community-acquired infections of mild-to-moderate severity, high-severity infections requiring broader gram-negative coverage, oral step-down therapy after initial intravenous treatment, and outpatient parenteral antibiotic management when drainage procedures are unlikely 1, 2

Levofloxacin provides excellent coverage against aerobic and facultative gram-negative bacteria, while metronidazole covers anaerobic organisms including Bacteroides fragilis 1, 2

The combination should not be used in regions with >20% fluoroquinolone-resistant E. coli for empiric therapy 3
The combination should be avoided in areas with high prevalence of ESBL-producing Enterobacteriaceae without susceptibility data 3

Fluoroquinolones may be used for intra-abdominal infections in children when susceptibility results support this choice and other options are limited 4, 3

The recommended dose is levofloxacin 500-750 mg daily plus metronidazole 500 mg every 8 hours (or equivalent dosing) 1, 2
The duration of treatment should typically not exceed 1 week for patients with adequate source control and resolution of clinical signs 1

There is no safety concern or drug interaction preventing concurrent use of metronidazole and levofloxacin 3, 5

Metronidazole should not be added unnecessarily when using agents that already provide adequate anaerobic coverage 5
Cultures should be obtained before initiating therapy when possible, and therapy should be narrowed based on susceptibility results 1, 2
Adequate source control is essential, as antimicrobials alone are insufficient without addressing the anatomical problem 1, 6